BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25079448)

  • 1. Illegal cosmetics on the EU market: a threat for human health?
    Desmedt B; Courselle P; De Beer JO; Rogiers V; Deconinck E; De Paepe K
    Arch Toxicol; 2014 Sep; 88(9):1765-6. PubMed ID: 25079448
    [No Abstract]   [Full Text] [Related]  

  • 2. [Expected change of direction in Polish law regarding cosmetics].
    Karłowski K; Smietanka B; Biernat U; Burzyńska I; Pawłowska K
    Rocz Panstw Zakl Hig; 2004; 55(1):21-5. PubMed ID: 15307612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The critical review of methodologies and approaches to assess the inherent skin sensitization potential (skin allergies) of chemicals. Part III.
    Thyssen JP; Giménez-Arnau E; Lepoittevin JP; Menné T; Boman A; Schnuch A
    Contact Dermatitis; 2012 Apr; 66 Suppl 1():53-70. PubMed ID: 22380842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myths, beliefs and fragrance allergy.
    Contact Dermatitis; 2013 Oct; 69(4):193-5. PubMed ID: 24028782
    [No Abstract]   [Full Text] [Related]  

  • 5. The critical review of methodologies and approaches to assess the inherent skin sensitization potential (skin allergies) of chemicals. Part II.
    Thyssen JP; Giménez-Arnau E; Lepoittevin JP; Menné T; Boman A; Schnuch A
    Contact Dermatitis; 2012 Apr; 66 Suppl 1():25-52. PubMed ID: 22380841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Good opportunities to prevent contact eczema through legislation].
    Lidén C
    Lakartidningen; 2002 Feb; 99(7):651-4. PubMed ID: 11887712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
    Pauwels M; Rogiers V
    Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin sensitisation.
    Basketter D; Casati S; Gerberick GF; Griem P; Philips B; Worth A
    Altern Lab Anim; 2005 Jul; 33 Suppl 1():83-103. PubMed ID: 16194142
    [No Abstract]   [Full Text] [Related]  

  • 9. Nickel on the Swedish market: follow-up 10 years after entry into force of the EU Nickel Directive.
    Biesterbos J; Yazar K; Lidén C
    Contact Dermatitis; 2010 Dec; 63(6):333-9. PubMed ID: 20812993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The critical review of methodologies and approaches to assess the inherent skin sensitization potential (skin allergies) of chemicals. Miscellaneous.
    Contact Dermatitis; 2012 Apr; 66 Suppl 1():1-9. PubMed ID: 22380839
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
    Lodén M; Ungerth L; Serup J
    Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European GMO labeling thresholds impractical and unscientific.
    Weighardt F
    Nat Biotechnol; 2006 Jan; 24(1):23-5. PubMed ID: 16404384
    [No Abstract]   [Full Text] [Related]  

  • 13. The 7th Amendment to the Cosmetics Directive.
    Ruet Rossignol M
    Altern Lab Anim; 2005 Jul; 33 Suppl 1():19-20. PubMed ID: 16194137
    [No Abstract]   [Full Text] [Related]  

  • 14. Nickel on the Dutch market: 10 years after entry into force of the EU Nickel Directive.
    Biesterbos J; Lidén C; van der Valk P
    Contact Dermatitis; 2011 Aug; 65(2):115-7. PubMed ID: 21745217
    [No Abstract]   [Full Text] [Related]  

  • 15. Model for tuning GMO detection in seed and grain.
    Macarthur R; Murray AW; Allnutt TR; Deppe C; Hird HJ; Kerins GM; Blackburn J; Brown J; Stones R; Hugo S
    Nat Biotechnol; 2007 Feb; 25(2):169-70. PubMed ID: 17287745
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety data requirements for the purposes of the Cosmetics Directive.
    Manou I; Eskes C; de Silva O; Renner G; Zuang V
    Altern Lab Anim; 2005 Jul; 33 Suppl 1():21-6. PubMed ID: 16194138
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenges related to cosmetic safety assessment in the EU.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():29-57. PubMed ID: 18806453
    [No Abstract]   [Full Text] [Related]  

  • 18. Is it time to revise CFR title 21-Food Drugs & Cosmetics Act for skin care products?
    Epstein HA
    Skinmed; 2013; 11(5):297-9. PubMed ID: 24340471
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of suspected illegal skin whitening cosmetics.
    Desmedt B; Van Hoeck E; Rogiers V; Courselle P; De Beer JO; De Paepe K; Deconinck E
    J Pharm Biomed Anal; 2014 Mar; 90():85-91. PubMed ID: 24334193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cosmetic products and their current European regulatory framework.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():1-28. PubMed ID: 18806452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.